/PRNewswire/ Indivior PLC (LON: INDV) today released the following statement regarding the US Drug Enforcement Administration s (DEA) recent memorandum to.
/PRNewswire/ Indivior PLC (LON: INDV) announces the publication of modeling data examining the competitive interaction between buprenorphine, a treatment.
Indivior (OTCMKTS:INVVY – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, […]
Indivior PLC (LON:INDV – Get Rating)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 301.67 ($3.95) and last traded at GBX 301.67 ($3.95), with a volume of 309609 shares. The stock had previously closed at GBX 285 ($3.73). Separately, Morgan Stanley initiated coverage […]
/PRNewswire/ Indivior PLC, (LON: INDV) today announced that further to its announcement on February 16, 2022, it is commencing formal consultations with.